Germany· DE-A57-b154259675f9c5e5
Megestat
A medicinal product containing megestrol acetate, registered in Germany by Bausch Health Ireland Limited.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Megestrol Acetate
- Manufacturer
- Bausch Health Ireland Limited
- Country
- Germany (DE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Megestrol acetate in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesMegestrol AcetatePreferred Pharmaceuticals Inc.
- United KingdomMegace 160mg tabletsAlliance Pharmaceuticals Ltd
- IrelandMegace 160 mg tabletsPCO Manufacturing Ltd.
- SpainBOREA 160 mg COMPRIMIDOSViatris Healthcare Limited
- CzechiaMEGACEBausch Health Ireland Limited, Dublin
- ItalyGESTROLTEXISTITUTO GENTILI S.R.L.
- FinlandMegaceBristol-Myers Squibb Ab
- PolandCachexanPolfarmex S.A.
Authorised across Europe · EMA
The same active substance is authorised in 21 EEA countries. Names it is sold under:
- Belgium · Megace
- Cyprus · Megace
- Czechia · Megace, Megaplex
- Spain · Borea, Maygace Altas Dosis
- France · Megace
- United Kingdom (Northern Ireland) · Megace
- Greece · Megace
- Croatia · Megace, Megostat
- Hungary · Cachexi, Megace
- Ireland · Megace
- Italy · Gestroltex, Megace
- Lithuania · Megace
- Luxembourg · Megace
- Netherlands · Megestrolacetaat Focus
- Norway · Megace
- Poland · Cachexan, Megace
- Portugal · Megace, Megestrol Generis
- Romania · Megesin
- Sweden · Megace
- Slovenia · Megace
- Slovakia · Megesin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a723341d-ef53-412f-a7f7-96b3a4b26fcb GET /v1/drugs/a723341d-ef53-412f-a7f7-96b3a4b26fcb?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Oral Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Megestrol Acetate",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about megestrol acetate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.